KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118,353 | +10.9% | 12,290 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $106,677 | +14.9% | 11,853 | +0.3% | 0.00% | 0.0% |
Q1 2023 | $92,858 | +18.6% | 11,814 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $78,274 | -53.7% | 11,579 | -0.4% | 0.00% | 0.0% |
Q3 2022 | $169,000 | +49.6% | 11,621 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $113,000 | -31.1% | 11,456 | +3.0% | 0.00% | 0.0% |
Q1 2022 | $164,000 | +4.5% | 11,119 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $157,000 | -17.4% | 11,901 | +9.4% | 0.00% | 0.0% |
Q3 2021 | $190,000 | -28.8% | 10,880 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $267,000 | -6.3% | 11,139 | +0.3% | 0.00% | 0.0% |
Q1 2021 | $285,000 | +77.0% | 11,105 | +30.9% | 0.00% | 0.0% |
Q4 2020 | $161,000 | +56.3% | 8,486 | +4.1% | 0.00% | – |
Q3 2020 | $103,000 | +2.0% | 8,154 | -2.2% | 0.00% | – |
Q2 2020 | $101,000 | +77.2% | 8,340 | +11.6% | 0.00% | – |
Q1 2020 | $57,000 | -59.6% | 7,472 | -5.5% | 0.00% | -100.0% |
Q4 2019 | $141,000 | +64.0% | 7,903 | +7.2% | 0.00% | – |
Q3 2019 | $86,000 | -47.6% | 7,371 | -0.7% | 0.00% | -100.0% |
Q2 2019 | $164,000 | – | 7,421 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 589,270 | $8,686,000 | 5.61% |
GREAT POINT PARTNERS LLC | 874,197 | $12,886,000 | 3.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 383,233 | $10,805,000 | 2.44% |
Frazier Life Sciences Management, L.P. | 1,572,192 | $23,174,000 | 1.98% |
TANG CAPITAL MANAGEMENT LLC | 648,269 | $9,555,000 | 1.91% |
Deep Track Capital, LP | 1,729,757 | $25,497,000 | 1.64% |
Vivo Capital, LLC | 1,533,559 | $22,605,000 | 1.56% |
Monashee Investment Management LLC | 264,111 | $3,893,000 | 1.13% |
COMMODORE CAPITAL LP | 312,553 | $4,607,000 | 1.03% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 | $25,740,000 | 0.79% |